TimesSquare Capital Management’s BioLife Solutions BLFS Stock Holding History

TimesSquare Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-547,350	Closed	-$12.5M	–	179
2022 Q3	$12.5M	Buy	547,350 +60,280	+12%	+$1.29M	0.17%	153
2022 Q2	$6.73M	Buy	487,070 +5,300	+1%	+$77.8K	0.09%	168
2022 Q1	$11M	Buy	481,770 +2,500	+0.5%	+$65.8K	0.12%	168
2021 Q4	$17.9M	Buy	479,270 +72,800	+18%	+$3.12M	0.16%	171
2021 Q3	$17.2M	Sell	406,470 -62,330	-13%	-$3M	0.15%	183
2021 Q2	$20.9M	Sell	468,800 -19,000	-4%	-$669K	0.17%	177
2021 Q1	$17.6M	Sell	487,800 -28,300	-5%	-$1.12M	0.15%	180
2020 Q4	$20.6M	Sell	516,100 -8,100	-2%	-$276K	0.17%	175
2020 Q3	$15.2M	Buy	+524,200	New	+$11.3M	0.14%	189

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

TimesSquare Capital Management's BLFS Position: Q4 2022 in Review

TimesSquare Capital Management sold out of BioLife Solutions (BLFS) in Q4 2022, closing a stake of 547,350 shares — an estimated $12.5M sold.

TimesSquare Capital Management first reported a position in BLFS in Q3 2020 and held it in 9 quarters. The position peaked at $20.9M in Q2 2021. 165 funds tracked by Wall St. Rank hold BLFS as of Q4 2022.

TimesSquare Capital Management reported no remaining BioLife Solutions position as of Q4 2022 after selling out during the quarter.
TimesSquare Capital Management sold 547,350 BioLife Solutions shares in Q4 2022, an estimated $12.5M.
TimesSquare Capital Management first reported a position in BioLife Solutions in Q3 2020 and held it in 9 quarters.
TimesSquare Capital Management's BioLife Solutions position peaked at $20.9M in Q2 2021.
165 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2022.

Based on TimesSquare Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.